Pharma Focus Asia
KP - Sustainable Packaging Solutions

Merck Announces its Plans to Invest US$1.12 billion at the Darmstadt Site until 2025


Merck Group announced its plans to invest US$1.12 billion in its Darmstadt site until 2025.


The aim of investing is to secure the future viability of company headquarters as a central science and technology hub and to further expand it.

The company management and employee representatives have likewise agreed to extend the employment guarantee until the end of 2025.

It also incorporates setting up a new Vocational and Advanced Training Center to provide qualification and advanced training among other programs to help employees transition into retirement.

This is in addition to its other Centers that encompass nearly five hundred employees in almost twenty-two vocational occupations to keep up with its continued requirement for trained workers.

The agreement on the future of the Darmstadt site is applicable until the end of 2025 for the roughly 11,000 employees of Merck KGaA in Darmstadt, Weiterstadt and Gernsheim.

It also encompasses the commitments on qualification and advanced training, for instance a new internal job placement office.

Moreover, the company management and employee representatives have agreed a voluntary leaver program and a bridge model for an early transition to retirement.


NameMerck Group Institute (HCI)
BudgetUS$1.12 billion
Parties InvolvedMerck Group
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?